Skip to main content

Table 1 LC–MS/MS characteristics of KZI in MRM mode

From: Kaliziri extract upregulates tyrosinase, TRP-1, TRP-2 and MITF expression in murine B16 melanoma cells

No.

Compound

Peak retention time (min)

Mr (relative molar mass)

Precursor ion (m/z)

Product ion (m/z)

1

4- O-caffeoylquinate

16.85

354

353.08

191.05

2

3-O-caffeoylquinate

17.46

354

353.06

191.04

3

5,7,3′,4′-tetrahydroxy-flavonone-3-O-glucoside

19.14

466

465.08

303.03

4

3′-methoxy-5,7,4′-trihydroxy-dihydrochalcone-3-O-rutinoside

20.13

628

627.41

465.19

5

3,4-di-O-caffeoylisoquinic acid

25.06

516

515.05

353.06

6

3,4-di-O-caffeoylquinic acid

25.81

516

515.05

353.09

7

Liquiritigenin

27.93

256

255.06

119.04

8

Luteolin

29.19

286

285.05

150.99

9

Butein

31.29

272

271.05

135.04

10

Apigenin

32.44

270

269.06

135.01

11

Methoxyisorhamnetin

33.51

330

329.23

199.12

12

Kaempferide

52.71

300

299.24

165.00

13

Vernodalinol

20.91

378

401.14

277.12

14

Vernodalol

22.89

392

415.11

291.10

15

Vernodalin

25.73

360

361.17

259.10